Polymorphonuclear leukocyte (PMN) membrane fluidity and PMN cytosolic Ca2+ content after activation in diabetes mellitus

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 11, Issue 4, 1998, Pages 237-241

  Lo Presti, R ^a   Canino, B ^a   Montana, M ^a   Ventimiglia, G ^a   Catania, A ^a   Caimi, G ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Diabetes mellitus; Polymorphonuclear leukocyte activation; Polymorphonuclear leukocyte cytosolic Ca2+ content; Polymorphonuclear leukocyte membrane fluidity

Indexed keywords

CALCIUM; FLUORESCENT DYE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLIBENCLAMIDE; GLICLAZIDE; INSULIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL MEMBRANE FLUIDITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0032469343     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Masuda M., Murakami T., Egawa H., Murata K.: Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats. Diabetes 39: 466-470, 1990.
2. Kantar A., Giorgi P.L., Curatola G., Fiorini R.: Alterations in membrane fluidity of diabetic polymorphonuclear leukocytes. Biochem. Med. Metab. Biol. 46: 422-426, 1991.
3. Tong P., Thomas T., Berrish T., Humphriss D., Barriocanal L., Stewart M., Walker M., Wilkinson R., Alberti K.G.M.M.: Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet 345: 357-358, 1995.
4. Alexiewicz J.M., Kumar D., Smogorszewski M., Klin M., Massry S.G.: Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann. Intern. Med. 123: 919-924, 1995.
5. 2+ content in different clinical conditions. Clin. Hemorheol. Microcirc. 17: 217-223, 1997.
6. Kinnunen P.K.J.: On the principles of functional ordering in biological membranes. Chem. Phys. Lipids 57: 375-399, 1991.
7. Devynck M.-A.: Do cell membrane dynamics participate in insulin resistance? Lancet 345: 336-337, 1995.
8. Berlin R.D., Fera J.P.: Changes in membrane microviscosity associated with phagocytosis. Effects of colchicine. Proc. Natl. Acad. Sci. USA 74: 1072-1076, 1977.
9. Ingraham L.M., Boxer L.A., Haak R.A., Baehner R.L.: Membrane fluidity changes accompanying phagocytosis in normal and in chronic granulomatous disease polymorphonuclear leukocytes. Blood 58: 830-835, 1981.
10. Pozzan T., Lew D.P., Wollheim C.B., Tsien R.Y.: Is cytosolic ionized calcium regulating neutrophil activation? Science 221: 1413-1415, 1983.
11. Marks P.W., Maxfield F.R.: Local and global changes in cytosolic free calcium in neutrophils during chemotaxis and phagocytosis. Cell Calcium 11: 181-190, 1990.
12. Carafoli E.: Calcium pump of the plasma membrane. Physiol. Rev. 71: 129-153, 1991.
13. Shinitzky M.: In: Shinitzky M. (Eds), Physiology of membrane fluidity. Vol. I., CRC, Boca Raton, 1984, pp. 1-51.
14. 2+ content after chemotactic activation. Clin. Hemorheol. 16: 523-531, 1996.
15. 2+ content after activation. Horm. Metab. Res. 30: 72-76, 1998.
16. Nash G.B., Jones J.G., Mikita J., Christopher B., Dormandy J.A.: Effects of preparative procedures and of cell activation on flow of white cells through micropore filters. Br. J. Hematol. 70: 171-176, 1988.
17. Pecsvarady Z., Fisher T.C., Fabok A., Coates T.D., Meiselman H.J.: Kinetics of granulocyte deformability following exposure to chemotactic stimuli. Blood Cells 18: 333-352, 1992.
18. Inoue S., Lan Y., Muran J., Tsuji M.: Reduced hydrogen peroxide production in neutrophils from patients with diabetes. Diabetes Res. Clin. Pract. 33: 119-127, 1996.
19. Mikita J., Nash G.: Dormandy J.: A simple method of preparing white blood cells for filterability testing. Clin. Hemorheol. 6: 635-639, 1996.
20. Lennie S.E., Lowe G.D.O., Barbenel J.C., Forbes C.D., Foulds W.S.: Filterability of white blood cell subpopulations, separated by an improved method. Clin. Hemorheol. 7: 811-816, 1987.
21. Yasui K., Masuda M., Matsuoka T., Yamazaki M., Komiyama A., Akabane T., Hasui M., Kobayashi Y., Murata K.: Abnormal membrane fluidity as a cause of impaired dynamics of chemoattractant receptors on neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by a membrane fluidizer. Pediatr. Res. 24: 442-446, 1988.
22. Masuda M., Komiyama Y., Murakami T., Murata K., Hasui M., Hirabayashi Y., Kobayashi Y.: Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-methionyl-leucyl-phenilalanine: role of excited oxygen species. J. Leukocyte Biol. 47: 105-110, 1990.
23. Donner M., Muller S., Stoltz J.F.: Molecular rheology of white blood cells. Rev. Port. Hemorreol. 3: 235-247, 1989.
24. Roe M.W., Lemasters J.J., Herman B.: Assessment of Fura 2 for measurements of cytosolic free calcium. Cell Calcium 11: 63-73, 1990.
25. Qvist R., Larkins R.G.: Decreased stimulated glucose oxidation and iodination by polymorphonuclear leukocytes from insulin-treated diabetic subjects. Diabetes 30: 256-262, 1981.
26. Esmann V.: The polymorphonuclear leukocyte in diabetes mellitus. J. Clin. Chem. Clin. Biochem. 21: 561-567, 1983.
27. Wilson R.M., Tomlinson D.R., Reeves W.G.: Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabetic Med. 4: 37-40, 1987.
28. Lagast H., Pozzan T., Waldvogel F.A., Lew P.D.: Phorbol myristate acetate stimulates ATP-dependent calcium transport by the plasma membrane of neutrophils. J. Clin. Invest. 73: 878-883, 1984.
29. Korchak H.M., Vienne K., Rutherford L.E., Wilkenfeld C., Finkelstein M.C., Weissmann G.: Stimulus response coupling in the human neutrophil. J. Biol. Chem. 259: 4076-4082, 1984.
30. White J.R., Naccache P.H., Molski T.P.P., Borgeat P., Sha'afi R.L.: Direct demonstration of increased intracellular concentration of free calcium in rabbit and human neutrophils following stimulation by chemotactic factor. Biochem. Biophys. Res. Commun. 113: 44-50, 1983.
31. Jeppesen J.L., Maheux P., Facchini F.S.: White blood cell count and insulin resistance in healthy nonsmoking men. Am. Heart J. 127: 459-461, 1994.
32. Targher G., Seidell J.C., Tonoli M., Muggeo M., De Sandre G., Cigolini M.: The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J. Intern. Med. 239: 435-441, 1996.